Location History:
- Hamburg, DE (1991)
- Bonn, DE (1992)
Company Filing History:
Years Active: 1991-1992
Title: Michael Neumaier: Innovator in Antibody Development
Introduction
Michael Neumaier is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antibodies. With a total of 2 patents, Neumaier's work has the potential to impact cancer treatment and diagnostics.
Latest Patents
One of his latest patents is the "Chimeric anti-CEA antibody," which describes a chimeric anti-CEA antibody comparable to ATCC Accession No. BH 8747. This innovation is crucial for advancing therapeutic options for patients with cancer.
Career Highlights
Neumaier is associated with City of Hope, a leading research and treatment center. His work there focuses on developing innovative solutions to combat cancer through advanced antibody technologies.
Collaborations
Throughout his career, Neumaier has collaborated with notable scientists, including John E. Shively and Arthur D. Riggs. These partnerships have enhanced the research and development of his patented technologies.
Conclusion
Michael Neumaier's contributions to the field of biotechnology, particularly in the development of chimeric antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment.